logo
Osmania University Results 2025 Out: Scorecards issued for regular, backlog courses at osmania.ac.in:

Osmania University Results 2025 Out: Scorecards issued for regular, backlog courses at osmania.ac.in:

Indian Express30-05-2025

Osmania University Results 2025 Out: Osmania University, Hyderabad has declared the results for undergraduate CBCS (Choice Based Credit System) programmes including BA, BCom, BSc, BBA, and BSW. Further, the results for IV and VI Semester Regular Examinations and the I, II, III, IV, V, and VI Semester Backlog Examinations conducted in April and May 2025 have been announced. Students who appeared in the regular or backlog exams earlier this year can now check their results on the official university website at osmania.ac.in/examination-results.
To access the results, students need to visit the university's result portal and enter their 12-digit hall ticket number. Once submitted, candidates will be able to view, download, and save their individual online mark sheets for future reference.
In case a student is dissatisfied with the marks awarded, they may apply for revaluation. For this, students must visit a TS Online Centre and submit a revaluation request along with the prescribed fee and a copy of the internet memo or marks memo.
Those wishing to obtain a photocopy of their evaluated answer script must fill out a proforma available on the official Osmania University website. Along with the application form, students must enclose a photocopy of their hall ticket and the downloaded memo. The fee for obtaining a photocopy is Rs 1000 per paper. It is important to note that the answer script photocopy will be sent to the student only via post.
Meanwhile, Osmania University has also announced the examination schedule for B.Pharmacy students with backlogs. The university will conduct the B.Pharmacy (PCI) VIII-Semester (Main and Backlog) and VII-Semester (Backlog) examinations in May–June 2025. The detailed time-table will be issued separately in due course.
As per the official notification, the schedule for payment of examination fees and submission of application forms is as follows:
For Students: The last date to pay the examination fee and submit the application form at their respective colleges is 17 June 2025.
For Colleges: The deadline for preparation and online submission of the Examination Application Forms (E.A.F) is 18 June 2025.
The examination fee is Rs 2360 for one or more papers in a semester. In addition, VIII-Semester students are required to pay an extra Rs 750 towards Consolidated Memorandum of Marks (CMM) and Provisional Certificate (PC). All regular students must also pay Rs 100 as a biometric attendance monitoring charge along with the exam fee.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP
Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP

News18

time24 minutes ago

  • News18

Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP

Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.

Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…
Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…

India.com

time27 minutes ago

  • India.com

Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…

Anil Ambani was already in the news for settling down the debt of his many companies. Now once again it has settled the debt with another company. In a recent exchange filing it stated that it has fully settled a Rs 273-crore loan, including interest, owed by its wholly owned subsidiary JR Toll Road Pvt Ltd (JRTR) to Yes Bank Ltd. It stated, '' A wholly owned subsidiary of the Company (along with the Company as Corporate Guarantor), has entered into an addendum to the Settlement Agreement today with Yes Bank Limited (YBL) for the entire outstanding debt obligation of ~INR 273 crore (including interest) owed by JRTR to YBL, and has duly paid the entire settlement amount.'' Anil Ambani Company Debt Reduction Debt reduction has become a primary focus for Anil Ambani. Reliance Infrastructure: Paid off Rs 3,300 crore of debt in FY 2025, becoming debt-free. Rosa Power Supply Company: Cleared Rs 485 crore of debt, achieving debt-free status. Reliance Power: Settled a loan of Rs 3,872 crore earlier. JR Toll Road Pvt Ltd, a special purpose vehicle established by Reliance Infrastructure, is responsible for the development, operation, and maintenance of a 52-kilometer segment of National Highway 11, connecting Jaipur and Reengus in Rajasthan. The project was executed under the Design-Build-Finance-Operate-Transfer (DBFOT) model, featuring a highway expansion from four to six lanes. Operations commenced in 2013, coinciding with the start of toll collection.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store